Jonas Brambeck

Jonas is senior investment director at Industrifonden and has more than two decades of experience within venture capital with focus on life science companies. He has participated in a great number of investments, divestments and listings over the years. Jonas has board experience from close to fifty companies, including listed ones. Prior to joining Industrifonden, Jonas held international sales, marketing and managerial positions with Bruker Instruments and prior to that research and development positions at Astra and Nobel. He has a Ph D in organic chemistry from the Royal Institute of Technology, Stockholm. In addition to Minervax, Jonas currently serves on the board of Gesynta Pharma, Oxthera, Avidicare (deputy) and Airsonett (deputy).